Advisory Board
Join Our Advisory BoardThe Pharma Focus Europe Advisory Board guides our current and upcoming leaders in the pharmaceutical sector in working smarter and faster. We offer provocative insights, practical tactics, and informative articles to enhance execution.
Subathra Ramamoorthy
Associate Principal Scientist, VeranovaSubathra Ramamoorthy is an Associate Principal Scientist at Veranova, bringing 15 years of experience in the pharmaceutical and life sciences industry. She has a proven track record of contributing to multiple ANDA and NDA filings across a diverse portfolio, including small molecules, drug substances, and complex generics. An active member of the American Association of Pharmaceutical Scientists (AAPS) and the Parenteral Drug Association (PDA), Subathra is a frequent speaker and author at various scientific forums, contributing her expertise to the advancement of the pharmaceutical sciences.
Vamsi Krishna Munagapati
Senior Director, PharmaronMr. Vamsi Krishna Munagapati is a seasoned professional with 23 years of global experience in the pharmaceutical industry, specializing in API and CDMO services. Currently serving as Senior Director at Pharmaron a leading multinational CRO and CDMO, he has previously held key roles at Dr. Reddy’s, Jubilant Life Sciences, Lupin, and Glenmark. With expertise in manufacturing, technology transfer, scale-up, and operational excellence, Vamsi leverages his background in chemical engineering and business administration to drive innovation and efficiency. A mentor and industry speaker, he is passionate about advancing pharmaceutical sciences and inspiring the next generation of engineers.
Aileen Lai
CEO & Founder HealthBeatsA global executive, Aileen Lai spent most of her career in Healthcare and Life Sciences, focusing on bringing technology and innovation to improve care. Her vast experience, extensive domain knowledge, and deep understanding of challenges in the healthcare industry contributed to the founding of HealthBeats®, a global remote vitals monitoring platform. Aileen holds the position of Vice-Chair, Digital Health, Start-ups & SMEs Committee of the Asia Pacific Medical Technology Association (APACMed). She also lectures and holds the position of course chair for Biomedical Informatics at the Bachelor level at the Singapore University of Social Sciences.
Dr. Siva Kumar Buddha
MBBS (MD), MBA, is the Director of Pharmacovigilance and Head of Signal and Risk Management, IndegeneDr. Siva Kumar Buddha, MBBS (MD), MBA, is the Director of Pharmacovigilance and Head of Signal and Risk Management at Indegene. He has extensive expertise in pharmacovigilance, driving automation initiatives. Beyond his professional role, he is an active speaker at both local and global pharmacovigilance conferences.
Victor M. Diaz Perez
Co-Founder and Operations Director, Solitek - Solid Technologies SL, SpainVictor completed his PhD. at the University of Seville, before moving to the UK in 1998 to held different positions as a synthetic and medicinal chemist. He started his journey in solid-state research in early 2007 at Pharmorphix (Cambridge, UK), as a Solid State Scientist, and left nearly 10 years later as Site Director, after having led the acquisition of the company by Johnson Matthey. He then moved to Northern Ireland to lead the Physical Sciences team at Almac for a further 5 years. In 2021, he cofounded Solitek (www.solitekpharma.com), a specialized solid state and preclinical development services company based in Spain, where he currently works as Operations Director.
Kishore Hotha
President, Dr.Hotha’s Life Sciences, USADr. Kishore Hotha is a scientific & business leader in the pharmaceutical biotech & CDMO. He contributed several IND, NDA & ANDAs of drug substances and products in small and large molecules, ADCs, Oligos, and peptides. He holds a Ph.D. from JNT University and an MBA from SNHU. Currently serving as President at Dr.Hotha’s Life Sciences, his career includes pivotal roles at Veranova, Lupin and Dr. Reddy’s, and he has contributed to over 80 publications and serving editorial boards.
Joab Williamson
Director, Clinical Operations, Faron Pharmaceuticals Ltd., United KingdomJoab Williamson is the Director, Clinical Operations at Faron Pharmaceuticals, a clinical stage biotech focusing on building the future of immune-oncology. In this role, Joab is responsible for the full oversight of clinical trials, and leading clinical strategy. He is also a PhD researcher with work focusing on how regulatory processes influence investment decisions and development timelines through the pharmaceutical industry.
Scott M. Wheelwright
Chief Operating Officer, BioInno Bioscience Co., Ltd. ChinaScott M. Wheelwright, Ph.D., is the founding Chief Operating Officer of BioInno Bioscience, a contract development and manufacturing organization (CDMO) in China that provides GMP production of antibodies, cell therapies, and gene therapies. Dr. Wheelwright was the founding COO of Innovent Biologics in China in 2010, a major biotech company in China. Dr. Wheelwright was a founder and principal of the consulting firms Strategic Manufacturing Worldwide, Inc. (located in Arizona), and Complya Asia (located in China). Dr. Wheelwright has thirty years of experience in bringing novel products to market, including new drug applications (BLAs and NDAs) in the US and Japan.
Gustavo Samojeden
CEO, Eriochem S.A, ArgentinaGustavo Samojeden is a Managing Director & CEO of Eriochem S.A. He is responsible for the full P&L of the group companies in Argentina, USA, Uruguay, Brazil, and México, and direct report to the group President. He is also a board member of the Uruguay affiliate.
.webp "Juris Hmelnickis")
Juris Hmelnickis
CEO, Grindeks, LatviaIn 2020 Juris became the Chairman of the Board of JSC Grindeks. Along with active professional activity in JSC Grindeks, he also held leading positions in the company’s subsidiary Kalceks. Currently, Hmelnickis holds the position of a member of the Board of Kalceks.
